Drugs / ACTD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03785574 | Dec 2018 → Sep 2030 expected | gestational trophoblastic neoplasm, hydatidiform mole | Women's Hospital School Of Medicine Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTD | “First line treatments：low risk：Methotrexate or ACTD; high risk：EMA-CO” NCT03785574 ↗ |